Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, Crossject SA (ALCJ.PA) has a market cap of $50.476 million USD. According to our data, Crossject SA is ranked No.8071 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $50.48 M |
-56.05%
|
| Dec 31, 2024 | $0.11 B |
-55.33%
|
| Dec 29, 2023 | $0.26 B |
50.83%
|
| Dec 30, 2022 | $0.17 B |
16.28%
|
| Dec 31, 2021 | $0.15 B |
-7.01%
|
| Dec 31, 2020 | $0.16 B |
33.26%
|
| Dec 31, 2019 | $0.12 B |
90.71%
|
| Dec 31, 2018 | $62.04 M |
-73.10%
|
| Dec 29, 2017 | $0.23 B |
3.28%
|
| Dec 30, 2016 | $0.22 B |
-53.95%
|
| Dec 30, 2015 | $0.48 B |
12.27%
|
| Dec 31, 2014 | $0.43 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
Israel
|
 Viatris
VTRS
|
$9.02 B |
-0.000 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
| Market Cap | = | ALCJ.PA Stock Price | * | ALCJ.PA Shares Outstanding |
| = | $1.07 | * | 46.09 M | |
| = | $50.48 M |